We are the Peptide Experts
JPT Peptide Technologies is the leading manufacturer of custom peptides and innovative peptide-based products for research and clinical applications. For more than 15 years we have been serving the worldwide biomedical community with science and quality driven products and services.
Located in our state-of-the-art laboratories in Berlin, Germany, JPT operates according to the most recent ISO 9001:2015 regulations.
NEW: Delta & Kappa SARS-CoV-2 PepMixes™
Identify Epitope Resolved Antibody Responses with SARS-CoV-2 Peptide Microarrays
In a recent publication using JPT’s RepliTope™ Antigen Collection Pan-Coronavirus peptide microarrays which display the whole SARS-CoV-2 proteome as well as relevant common cold corona virus antigens, a widespread cross-reactivity was detected across immunodominant antigen regions. Importantly, a statistically significant discrimination between COVID-19 patients and controls could be achieved allowing selection of dedicated peptides for further development.
NEW: Virus-spanning PepMix™ Select Epitope Pools from JPT
We are happy to expand our PepMix™ Pool portfolio with a new line of PepMix™ Select Pools:
- Virus-specific epitope pools for CMV, EBV, BKV, HHV6 and HAdV5
- Multiple antigens covering the whole virus in one pool
- Defined HLA class I & II-restricted immunodominant T-cell epitopes
- Elicit virus-specific strong immune responses